Shin Nippon Biomedical Laboratories, Ltd.

Informe acción TSE:2395

Capitalización de mercado: JP¥64.7b

Salud financiera de hoja de balance de Shin Nippon Biomedical Laboratories

Salud financiera controles de criterios 3/6

Shin Nippon Biomedical Laboratories tiene un patrimonio de accionistas total de ¥36.5B y una deuda total de ¥35.0B, lo que sitúa su ratio deuda-patrimonio en 95.9%. Sus activos y pasivos totales son ¥89.0B y ¥52.5B respectivamente. El BAIT de Shin Nippon Biomedical Laboratories es de ¥1.9B, por lo que su ratio de cobertura de intereses es de 59.1. Tiene efectivo e inversiones a corto plazo que ascienden a ¥11.2B.

Información clave

95.9%

Ratio deuda-patrimonio

JP¥34.96b

Deuda

Ratio de cobertura de intereses59.1x
EfectivoJP¥11.21b
PatrimonioJP¥36.45b
Total pasivoJP¥52.53b
Activos totalesJP¥88.98b

Actualizaciones recientes sobre salud financiera

No hay actualizaciones

Recent updates

What Shin Nippon Biomedical Laboratories, Ltd.'s (TSE:2395) 25% Share Price Gain Is Not Telling You

Nov 25
What Shin Nippon Biomedical Laboratories, Ltd.'s (TSE:2395) 25% Share Price Gain Is Not Telling You

Shin Nippon Biomedical Laboratories' (TSE:2395) Dividend Will Be ¥20.00

Sep 19
Shin Nippon Biomedical Laboratories' (TSE:2395) Dividend Will Be ¥20.00

Earnings Miss: Shin Nippon Biomedical Laboratories, Ltd. Missed EPS By 88% And Analysts Are Revising Their Forecasts

Aug 09
Earnings Miss: Shin Nippon Biomedical Laboratories, Ltd. Missed EPS By 88% And Analysts Are Revising Their Forecasts

Little Excitement Around Shin Nippon Biomedical Laboratories, Ltd.'s (TSE:2395) Earnings As Shares Take 28% Pounding

Aug 06
Little Excitement Around Shin Nippon Biomedical Laboratories, Ltd.'s (TSE:2395) Earnings As Shares Take 28% Pounding

Shin Nippon Biomedical Laboratories' (TSE:2395) Dividend Will Be ¥20.00

Jul 26
Shin Nippon Biomedical Laboratories' (TSE:2395) Dividend Will Be ¥20.00

Shin Nippon Biomedical Laboratories' (TSE:2395) Dividend Will Be ¥20.00

Jul 12
Shin Nippon Biomedical Laboratories' (TSE:2395) Dividend Will Be ¥20.00

Shin Nippon Biomedical Laboratories' (TSE:2395) Sluggish Earnings Might Be Just The Beginning Of Its Problems

May 21
Shin Nippon Biomedical Laboratories' (TSE:2395) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Shin Nippon Biomedical Laboratories, Ltd. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

May 10
Shin Nippon Biomedical Laboratories, Ltd. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Shin Nippon Biomedical Laboratories (TSE:2395) Is Due To Pay A Dividend Of ¥30.00

Mar 12
Shin Nippon Biomedical Laboratories (TSE:2395) Is Due To Pay A Dividend Of ¥30.00

Shin Nippon Biomedical Laboratories (TSE:2395) Has Affirmed Its Dividend Of ¥30.00

Feb 27
Shin Nippon Biomedical Laboratories (TSE:2395) Has Affirmed Its Dividend Of ¥30.00

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (¥34.0B) de 2395 superan a sus pasivos a corto plazo (¥28.8B).

Pasivo a largo plazo: Los activos a corto plazo de 2395 (¥34.0B) superan a sus pasivos a largo plazo (¥23.7B).


Historial y análisis de deuda-patrimonio

Nivel de deuda: La relación deuda neta-capital de 2395 (65.2%) se considera alta.

Reducción de la deuda: El ratio deuda-patrimonio de 2395 ha crecido de 67% a 95.9% en los últimos 5 años.

Cobertura de la deuda: La deuda de 2395 no está bien cubierta por el flujo de caja operativo (4.7%).

Cobertura de intereses: Los pagos de intereses de la deuda de 2395 están bien cubiertos por el BAIT (59.1x cobertura).


Hoja de balance


Descubre empresas con salud financiera